Technology
Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies
Cortechs.ai, a global leader in AI-powered neuroimaging solutions, today announced a strategic partnership with Siemens Healthineers to integrate and distribute Cortechs.ai's FDA-cleared NeuroQuant® Lesion Surveillance through the Siemens Healthineers Digital Marketplace. The collaboration is designed to accelerate the worldwide adoption of quantitative brain imaging, improving diagnostic precision, optimizing clinical workflows, and ultimately enhancing patient care in neurology, especially for
About this update from Siemens Healthineers Ag
[{"type":"text","content":"SAN DIEGO, March 4, 2026 /PRNewswire/ -- Cortechs.ai, a global leader in AI-powered neuroimaging solutions, today announced a strategic partnership with Siemens Healthineers to integrate and distribute Cortechs.ai's FDA-cleared NeuroQuant® Lesion Surveillance through the Siemens Healthineers Digital Marketplace. The collaboration is designed to accelerate the worldwide adoption of quantitative brain imaging, improving diagnostic precision, optimizing clinical workflows, and ultimately enhancing patient care in neurology, especially for complex dementia care pathways.","length":577,"tagName":"p"},{"type":"image","alt":"Cortechs.ai Logo (PRNewsfoto/Cortechs.ai)","displaySize":"","headline":null,"caption":"Cortechs.ai Logo (PRNewsfoto/Cortechs.ai)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":57,"url":"https://media.zenfs.com/en/prnewswire.com/8e864f05e59ee8064333934ed20d31f7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pSE.knJaMHEMzYVaV0x_Fw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/8e864f05e59ee8064333934ed20d31f7","width":400,"height":57}},"href":"https://mma.prnewswire.com/media/2378360/Cortechsai_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The expanded portfolio includes the latest FDA‑cleared NeuroQuant® Lesion Surveillance module, which uniquely provides automated segmentation and volumetric quantification, along with longitudinal tracking of lesion size and dynamics over time. These capabilities provide clinicians with important quantitative insights to support assessment across a broad range of neurological conditions, including the early detection and monitoring of ARIA in Alzheimer's patients receiving anti‑amyloid therapies.","length":505,"tagName":"p"},{"type":"text","content":""This partnership with Siemens Healthineers marks a pivotal step in expanding access to advanced neuroimaging on a global scale," said Kyle Frye, CEO of Cortechs.ai. "By combining our innovative AI technologies with Siemens Healthineers' unmatched reach and imaging expertise, we're equipping clinicians with faster, more precise insights to make better-informed decisions around Alzheimer's and ARIA care."","length":439,"tagName":"p"},{"type":"text","content":"This partnership wil...